WaveMan
WaveMan · Company
DHC · Diversified Healthcare Trust
> Search tickers & screens ⌘K
LIVE
← All companies

DHC Diversified Healthcare Trust (DHC) Insider Trading, Ownership & Congress Trades

Real Estate · Real estate investment trusts · CIK 0001075415
Quote by TradingView
SEC filings
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
135
13F, latest reported quarter

Diversified Healthcare Trust insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

No insider purchases or sales are on record for DIVERSIFIED HEALTHCARE TRUST in the period covered. Source: SEC Form 4 filings, as of 2026-10-29.

Insider
Filed
Shares
Value
Since filing
Bilotto Christopher J.
President and CEO
BUY
2025-12-16 SECtraded 2025-12-15
20,000
$97.8K
+56.8%
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • The trade is 7.5% of the 266,284 shares held after it.
  • No other insider bought within 30 days.
  • 135 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: President and CEO Bilotto Christopher J. bought about $97.8K of DHC on Dec 15, 2025, the largest insider purchase at the company since 2023; 135 funds added in the latest 13F quarter.
Brown Matthew C.
CFO and Treasurer
BUY
2024-11-14 SECtraded 2024-11-13
2,000
$5.1K
+213.7%
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • The trade is 2.3% of the 86,282 shares held after it.
  • No other insider bought within 30 days.
  • 135 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: CFO and Treasurer Brown Matthew C. bought about $5.1K of DHC on Nov 13, 2024, the largest insider purchase at the company since 2023; 135 funds added in the latest 13F quarter.
PORTNOY ADAM D.
Director
BUY
2023-06-14 SEC
2,000,000
$6.1M
+181.9%
Context
  • 11 earlier Form 4 trades (code P or S) here by this insider (11 buys), the last on Jun 13, 2023.
  • +30.8% median (+37.4% mean) 90-day return after 11 previous buys.
  • The trade is 8.6% of the 23,250,019 shares held after it.
  • No other insider bought within 30 days.
  • 135 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director PORTNOY ADAM D. bought about $6.1M of DHC on Jun 14, 2023, the largest insider purchase at the company on our record; 135 funds added in the latest 13F quarter.
PORTNOY ADAM D.
Director
BUY
2023-06-14 SECtraded 2023-06-13
1,992,259
$6.0M
+181.9%
Context
  • 10 earlier Form 4 trades (code P or S) here by this insider (10 buys), the last on Jun 12, 2023.
  • +39.8% median (+43.8% mean) 90-day return after 10 previous buys.
  • The trade is 9.4% of the 21,250,019 shares held after it.
  • No other insider bought within 30 days.
  • 135 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director PORTNOY ADAM D. bought about $6.0M of DHC on Jun 13, 2023, the largest insider purchase at the company on our record; 135 funds added in the latest 13F quarter.
PORTNOY ADAM D.
Director
BUY
2023-06-14 SECtraded 2023-06-12
2,011,256
$5.8M
+181.9%
Context
  • 9 earlier Form 4 trades (code P or S) here by this insider (9 buys), the last on Jun 9, 2023.
  • +48.8% median (+51.4% mean) 90-day return after 9 previous buys.
  • The trade is 10.4% of the 19,257,760 shares held after it.
  • No other insider bought within 30 days.
  • 135 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director PORTNOY ADAM D. bought about $5.8M of DHC on Jun 12, 2023, the largest insider purchase at the company on our record; 135 funds added in the latest 13F quarter.
14 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
See all insider buying · insider selling
Showing the latest few. to see 9 more transactions and use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
no insider buys or sells on file
Congress
no House purchase disclosed in the last 12 months
Funds
135 funds bought in last quarter
more than 54% of Real Estate
Revenue
+2.8% year over year
below 56% of Real Estate
Margin
-18.6% net margin
below 81% of Real Estate
Buybacks
$138.0K repurchased, FY to 2026-06-30
below 95% of Real Estate
Short interest
5.8% of the float short (float per yahoo 2026-10-27) · 5.8 days to cover · settled 2026-10-15
more than 58% of Real Estate
What changed in the last 30 days
Nothing new filed in the last 30 days

Watch DHC

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+81.7%12M
-4%+39%+82%+126%2025-102025-122026-022026-042026-062026-082026-10 2025-12-15 · Bilotto Christopher J. bought $97.8K
Insider buy
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns DHC: institutional holders (13F)

13F holdings, latest reported quarter
Flat Footed LLC
23,487,002 sh
$218.4M
BlackRock, Inc.
23,076,173 sh
$214.6M
Silver Point Capital L.P.
15,504,810 sh
$144.2M
VANGUARD PORTFOLIO MANAGEMENT LLC
10,592,743 sh
$98.5M
VANGUARD CAPITAL MANAGEMENT LLC
9,675,173 sh
$90.0M

Congress trades in DHC

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

DHC planned insider sales (Form 144)

No planned-sale notices
No insider has filed to sell. Watch this after a run-up.

DHC mutual fund holders (N-PORT)

Funds ranked by the share of their own portfolio in this stock (N-PORT).
Hennessy Cornerstone Growth Fund
$10.7M position · as of 2026-07-31
2.2%
Even Herd Long Short ETF
$1.2M position · as of 2026-06-30
2.0%
Putnam VT Small Cap Value Fund
$1.4M position · as of 2026-06-30
1.1%
Putnam Small Cap Value Fund
$3.3M position · as of 2026-05-31
1.1%
First Trust Small Cap Growth AlphaDEX Fund
$8.4M position · as of 2026-07-31
0.6%
PIMCO RealEstateRealReturn Strategy Fund
$3.5M position · as of 2026-06-30
0.6%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M · % is the share of the fund's own portfolio
Executive pay vs shareholder return · Jennifer F. Francis
CEO pay, headline and as actually paid, against the company's return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2023
$178.7K
$508.0K
$19.1K
-50%
-7%
2022
$124.0K
-$75.7K
$53.8K
-92%
-18%
2021
$280.4K
$231.1K
$103.5K
-61%
+5%
2020
$116.4K
$58.3K
$78.2K
-48%
-10%
Tagged by the company under SEC Item 402(v). Returns are cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows 135 funds added last quarter. Each figure is a federal filing, dated the day it went public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector by SEC SIC code
EQIXBRTACRFPHIRMNYCSPGOPENMDVMDRRAATAXR

DHC financials

Revenue growth
+2.8%
XBRL, annual
Net margin
-18.6%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$1.5B
four quarters, 2025-07-01 to 2026-06-30
Net margin, TTM
-17.7%
net income over revenue, 2025-07-01 to 2026-06-30
Free cash flow, TTM
-$155.0M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Debt to equity
1.99x
long-term 2026-06-30 plus current 2023-09-30 (33 months older than the period end); equity 2026-06-30
Cash flow to debt
-0.01x
TTM operating cash flow over long-term 2026-06-30 plus current 2023-09-30 (33 months older than the period end)
Return on equity
-15.5%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets
-5.9%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on invested capital
n/a
pre-tax loss, no effective tax rate to apply
Return on capital employed
n/a
assets or current liabilities not filed
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
Enterprise value
$4.9B
market value at close 2026-10-27 on 2026-07-31 shares, plus long-term 2026-06-30 plus current 2023-09-30 (33 months older than the period end), minus cash 2026-06-30
FCF yield
-8.3%
TTM free cash flow over market value at close 2026-10-27
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
Price as of 2026-10-27. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2025-122024-122023-122022-12
Revenue$1.5B$1.5B$1.4B$1.3B
Net income-$285.9M-$370.3M-$293.6M-$15.8M
EPS (diluted)-1.19-1.55-1.23-0.07
Operating cash flow-$19.6M$112.2M$10.5M-$40.4M
Cash$105.4M$144.6M$245.9M$658.1M
Long-term debt$2.4B$3.1Bn/an/a
Buybacks$1.1M$904.0K$393.0K$171.0K
Dividends paid$9.7M$9.6M$9.6M$9.6M
SEC XBRL, fiscal years, as known on 2026-10-29

DHC Stock Sonar score 5/7 axes

Find similar shapesCompare

DHC ranks highest on institutional and government (54th percentile) and growth (44th), and lowest on profitability (15th), among Real Estate peers.

ProfitHealthGrowthInstitutionsRisk
Profitability
15
Inputs
  • Return on equity-15.5% · 15 pct, sector of 230
  • Return on assets-5.9% · 15 pct, sector of 255
  • Return on invested capitalpre-tax loss, no effective tax rate to apply
  • Return on capital employedassets or current liabilities not filed
Financial health
19
Inputs
  • Debt to equity1.99x · 26 pct, sector of 210
  • Cash flow to debt-0.01x · 12 pct, sector of 215
Growth
44
Inputs
  • Revenue growth, YoY+2.8% · 44 pct, sector of 244
  • Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Institutional and government
54
Inputs
  • Funds adding, latest quarter135 · 54 pct, sector of 171
  • Congress net buyers, 365dno Congress trades in 365 days
  • Federal contracts, 180dno federal contracts in 180 days
  • Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
42
Inputs
  • Short interest, % of float+5.8% · 38 pct, sector of 258
  • Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
  • EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
  • New text in Risk Factors, latest 10-K+9.2% · 46 pct, sector of 212
2 not measured: Insider conviction, US patents
  • Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing
Insider buyingInsider sellingCongress stock tradesActivist 13D stakesForm 144 planned salesCEO pay vs performanceAll companies